Navigation Links
Silicone Scandal: Stem Cell Breast Augmentation a Safe Alternative

VIENNA, Austria, January 10, 2012 /PRNewswire/ --

Stem cell-enriched autologous fat enables sustainable breast augmentation with autologous tissue

It was in all the media: For years a French company has been selling defective silicone implants that often rupture and may cause cancer. More than 100,000 women worldwide must now choose between having their implants removed as a precaution or carrying a "time bomb" in their bodies. Stem cell breast augmentation offers an innovative, safe alternative to silicone implants.

"Autologous fat tissue is better tolerated than silicone and is ideal for scarless, completely natural breast augmentation or breast reconstruction after removal of silicone implants or tumors," says DDr. Karl-Georg Heinrich, Vienna-based esthetic and regenerative stem cell therapy expert. His Clinic DDr. Heinrich® has been granting the wishes of patients worldwide for a fuller décolletage without silicone and scars since 2007.

Like all other approved silicone implants, the defective French implants were also CE certified. The defects of these implants remained hidden. But even the best silicone implants represent only a temporary breast augmentation solution. Hence cosmetic surgeons who use silicone implants recommend implant replacements every ten years for all patients.

With stem cell breast augmentation, however, sustainable breast augmentation is generally achievable with just one intervention under local anesthesia. The autologous fat used for breast augmentation is gently liposuctioned with patented microcannulas, enriched with autologous stem cells, and then injected in the breast with fine injection needles.

Along with breast augmentation and stem cell facelifts, stem cell-enriched autologous fat is used in the Clinic DDr. Heinrich® for body shaping (buttocks, hips, upper thighs, calves) as well as dent correction and skin rejuvenation.

Further information:

Clinic DDr. Heinrich®
Contact: Herfried Wagner
Phone: +43-(0)1-532-18 01

SOURCE Clinic DDr. Heinrich
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Microban Medical Silver Antimicrobial Technologies for HCR Silicone Achieve 5 Log Reductions in Bacteria Growth and Prevent Biofilm Formation
2. Saint-Gobain Introduces Next Generation Silicone Tubing
3. Polymer Science Releases New Silicone Gel Adhesive Products for MD&M West
4. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
5. BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research
6. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
7. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
8. Agendia to Present Five Abstracts at 2011 San Antonio Breast Cancer Symposium
9. Novartis Highlights Advances for Patients With Breast Cancer and Hematological Diseases With Over 160 SABCS and ASH Abstracts
10. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
11. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):